Brian Hiestand to Predictive Value of Tests
This is a "connection" page, showing publications Brian Hiestand has written about Predictive Value of Tests.
Connection Strength
0.217
-
Hiestand B. Measuring the agreement between two tests for determining blood alcohol concentrations. Acad Emerg Med. 2005 Mar; 12(3):271; author reply 271.
Score: 0.054
-
Riley RF, Miller CD, Russell GB, Soliman EZ, Hiestand BC, Herrington DM, Mahler SA. Usefulness of Serial 12-Lead Electrocardiograms in Predicting 30-Day Outcomes in Patients With Undifferentiated Chest Pain (the ASAP CATH Study). Am J Cardiol. 2018 08 01; 122(3):374-380.
Score: 0.033
-
Mahler SA, Stopyra JP, Apple FS, Riley RF, Russell GB, Hiestand BC, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Herrington DM, Burke GL, Miller CD. Use of the HEART Pathway with high sensitivity cardiac troponins: A secondary analysis. Clin Biochem. 2017 May; 50(7-8):401-407.
Score: 0.030
-
Askew KL, O'Neill JC, Hiestand B, Manthey DE. Combined Versus Detailed Evaluation Components in Medical Student Global Rating Indexes. West J Emerg Med. 2015 Nov; 16(6):885-8.
Score: 0.028
-
Mahler SA, Riley RF, Hiestand BC, Russell GB, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Elliott SB, Herrington DM, Burke GL, Miller CD. The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):195-203.
Score: 0.027
-
Miller CD, Case LD, Little WC, Mahler SA, Burke GL, Harper EN, Lefebvre C, Hiestand B, Hoekstra JW, Hamilton CA, Hundley WG. Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain. JACC Cardiovasc Imaging. 2013 Jul; 6(7):785-94.
Score: 0.024
-
Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, Clopton P, van Veldhuisen DJ. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail. 2011 Aug; 13(8):846-51.
Score: 0.021